In recent years, several lines of evidence have implicated that cuproptosis-related genes, including SLC31A1, DLAT, and ATP7B, could serve as potential diagnostic and therapeutic targets for BC (Li et al. 2022a, b). Here, SLC31A1 is linked to breast cancer.